St. Joseph Health, Queen of the Valley Ranked in Healthgrades America's 250 Best Hospitals™ list.

February 20, 2019 Providence News Team

Share this Article
Facebook
Twitter
LinkedIn

St. Joseph Health, Queen of the Valley recently ranked in Healthgrades America's 250 Best Hospitals™ list. The list is based on providing exceptional quality outcomes for 32 conditions and procedures. This recognition places Queen of the Valley in the top 5 percent in the nation for overall clinical excellence for the current year. Queen of the Valley was one of seven Providence St. Joseph Health hospitals that made the Healthgrades America's Best Hospitals™ list. For more information, visit https://www.healthgrades.com/quality/americas-best-hospitals-for-2019.

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

Hundreds to be served in bold proposal to slash chronic homelessness by 20 percent

Hundreds to be served in bold proposal to slash chronic homelessness by 20 percent in Catholic Charities, A...

New CT Simulator at Queen of the Valley Enhances Quality of Care for Oncology Patients

Queen of the Valley Medical Center announced today it installed a new Canon Medical Aquilion Large Bore com...

Most Recent Articles

Growing hope

St. Joseph Health, Queen of the Valley Ranked in Healthgrades America's 250 Best Hospitals™ list.

About the Author

Previous Article

Next Article

Most Recent Articles

When a stroke robbed Lauren of her balance, the team on 4K – Providence Acute Rehabilitation Center – helped her regain what she lost with a little help from sunflowers, marigolds and little bugs.

The bariatric programs at Providence Little Company of Mary’s San Pedro and Torrance locations offer effective, long-term weight-loss solutions.

Providence South Division Cancer Institute earns national recognition as a top cancer program

Hospital program the only one recognized in Greater L.A. Area

More than 2,000 years ago, Hippocrates—the father of modern medicine—suggested that all diseases begin in the gut. With mounting evidence showing a connection between gut health and everything from au

Grounding allows us to use the earth’s negative electric charge to stabilize and rebalance our body’s accumulated positive charges. Contact with the vast supply of electrons on the earth’s surface—thi

Despite the sometimes dramatic improvements that have been made in other cancers, lung cancer survival has only slightly improved over the past several decades. Fortunately, that’s beginning to change

Rob Sears had been troubled by an increasingly erratic heartbeat for years. He finally found help from Dr. Shephal Doshi and a leading-edge minimally invasive procedure.

A special request for our patients and visitors – Farsi and Spanish translation further below:

R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.

The team at the Adult and Pediatric Cochlear Implant Program, Dr. Courtney Voelker and Dr. Rebecca Lewis, restored Father Timothy McGowan’s hearing so he could get back to the work he loves.

Kadlec offering Prevention4ME for detection of breast and other cancers.

The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.

In 2023, Providence Alaska contributed $265,000 to Catholic Social Services’ Medical Respite program, which provides recuperative living quarters for patients experiencing homelessness.

Learn why a proposed FSED is not right for our community.

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.